Capital Pool Company Enters into Definitive Agreement for Qualifying Transaction with Pharmaceutical Company

AAJ Capital 3 Corp. Announces Definitive Agreement for Qualifying Transaction with XRP Healthcare M&A Holding Inc.

AAJ Capital 3 Corp., a capital pool company, has announced that it has entered into a definitive agreement with XRP Healthcare M&A Holding Inc. for a qualifying transaction. The proposed acquisition will see AAJ acquire all of the issued and outstanding shares of Pharma Ville Limited, a well-established pharmaceutical company based in Kampala, Uganda.

As part of the deal, AAJ shareholders will receive 0.45% of the combined entity’s shares, while XRP Healthcare M&A Holding Inc. will hold 100% of the acquired Pharma Ville Shares. The transaction is subject to customary conditions and approvals, including the acceptance by the TSX Venture Exchange (TSXV) and approval of AAJ shareholders.

The acquisition is expected to create a significant player in the pharmaceutical industry with a strong presence in Africa. XRP Healthcare M&A Holding Inc., through its wholly-owned subsidiary Pharma Ville Limited, has established itself as a well-established pharmaceutical company, operating seven branches including five wholesale distribution centers and two retail pharmacies.

Under the terms of the agreement, AAJ Capital 3 Corp. will acquire all outstanding shares of Pharma Ville Limited for an undisclosed amount. The transaction is expected to be completed in due course and is subject to certain conditions, including the satisfaction of regulatory requirements and approval by relevant authorities.

The proposed transaction does not constitute a “Non-Arm’s Length Qualifying Transaction” as per TSXV policies and will require approval from the AAJ shareholders at an annual and special meeting. The company has announced that trading in its securities has been halted pending completion of the transaction, which is expected to resume once all conditions have been met.

The acquisition is a significant milestone for both parties, as it marks a strategic partnership that aligns with their respective business objectives. AAJ Capital 3 Corp.’s management expressed their excitement about this development and emphasized the benefits it will bring to its shareholders.

“We are thrilled to announce this definitive agreement, which we believe will unlock tremendous value for our shareholders,” said Peeyush Varshney, CEO of AAJ Capital 3 Corp. “We look forward to working closely with XRP Healthcare M&A Holding Inc.’s team to complete the acquisition and list on the TSX Venture Exchange.”

Kain Roomes, founder and chairman of XRP Healthcare M&A Holding Inc., also expressed his enthusiasm about this partnership: “I am extremely pleased that we have reached a definitive agreement. Our company is dedicated to providing high-quality healthcare services in Africa, and this acquisition will enable us to scale our operations exponentially. We are excited to embark on this journey with AAJ Capital 3 Corp.”

XRP Healthcare M&A Holding Inc.’s advisors, ARC Group Limited, acted as its exclusive financial advisor for the transaction, while Oakridge Law LLP (Ontario) provided legal counsel.

For more information about this announcement and any related matters, investors are advised to refer to the company’s SEDAR+ profile at www.sedarplus.ca.

Source: cryptocurrencynews.com